Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease

被引:452
作者
Egami, Kimiyasu
Muta, Hiromi
Ishii, Masahiro
Suda, Kenji
Sugahara, Yoko
Iemura, Motofumi
Matsuishi, Toyojiro
机构
[1] Kurume Univ, Dept Pediat, Kurume, Fukuoka 830, Japan
[2] Kitasato Univ, Dept Pediat, Sagamihara, Kanagawa 228, Japan
关键词
D O I
10.1016/j.jpeds.2006.03.050
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives The objective of this study was to find the predictors and generate a prediction score of resistance to intravenous immunoglobulin (IVIG) in patients with Kawasaki disease (KD). Study design Patients diagnosed as having KD were sampled when they received initial high-dose IVIG treatment (2 g/kg dose) within 9 days of illness (n = 320). These patients were divided into 2 groups: the resistance (n = 41) and the responder (n = 279). The following data were obtained and compared between resistance and responder: age, sex, illness days at initial treatment, and laboratory data. Results Multivariate logistic regression analysis identified age, illness days, platelet count, alanine aminotransferase (ALT), and C-reactive protein (CRP) as significant predictors for resistance to IVIG. We generated prediction score assigning I point for (1) infants less than 6 months old, (2) before 4 days of illness, (3) platelet count <= 30 x 10(10)/L, (4) CRP >= 8 mg/dL, as well as 2 points for (5) ALT >= 80 IU/L. Using a cut-off point of 3 and more with this prediction score, we could identify the IVIG-resistant group with 78% sensitivity and 76% specificity. Conclusions Resistance to IVIG treatment can be predicted using age, illness days, platelet. count, ALT, and CRP. Randomized, multicenter clinical trials are necessary to create a new strategy to treat these high-risk patients.
引用
收藏
页码:237 / 240
页数:4
相关论文
共 28 条
  • [1] Infliximab treatment for refractory Kawasaki syndrome
    Burns, JC
    Mason, WH
    Hauger, SB
    Janai, H
    Bastian, JF
    Wohrley, JD
    Balfour, I
    Shen, CA
    Michel, ED
    Shulman, ST
    Melish, ME
    [J]. JOURNAL OF PEDIATRICS, 2005, 146 (05) : 662 - 667
  • [2] Intravenous gamma-globulin treatment and retreatment in Kawasaki disease
    Burns, JC
    Capparelli, EV
    Brown, JA
    Newburger, JW
    Glode, MP
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (12) : 1144 - 1148
  • [3] A comparison of C/B ratios from studies using receiver operating characteristic curve analysis
    Cantor, SB
    Sun, CC
    Tortolero-Luna, G
    Richards-Kortum, R
    Follen, M
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (09) : 885 - 892
  • [4] Coronary artery dimensions may be misclassified as normal in Kawasaki disease
    de Zorzi, A
    Colan, SD
    Gauvreau, K
    Baker, AL
    Sundel, RP
    Newburger, JW
    [J]. JOURNAL OF PEDIATRICS, 1998, 133 (02) : 254 - 258
  • [5] Immunoglobulin failure and retreatment in Kawasaki disease
    Durongpisitkul, K
    Soongswang, J
    Laohaprasitiporn, D
    Nana, A
    Prachuabmoh, C
    Kangkagate, C
    [J]. PEDIATRIC CARDIOLOGY, 2003, 24 (02) : 145 - 148
  • [6] Prediction of non-responsiveness to intravenous high-dose γ-globulin therapy in patients with Kawasaki disease at onset
    Fukunishi, M
    Kikkawa, M
    Hamana, K
    Onodera, T
    Matsuzaki, K
    Matsumoto, Y
    Hara, J
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (02) : 172 - 176
  • [7] FURUKAWA S, 1993, RIUMACHI KA, V9, P165
  • [8] Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease
    Han, RK
    Silverman, ED
    Newman, A
    McCrindle, BW
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (07): : 694 - 699
  • [9] Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805
  • [10] Treatment of acute Kawasaki disease: Aspirin's role in the febrile stage revisited
    Hsieh, KS
    Weng, KP
    Lin, CC
    Huang, TC
    Lee, CL
    Huang, SM
    [J]. PEDIATRICS, 2004, 114 (06) : E689 - E693